Crescent-shaped meta-substituted benzene derivatives as a new class of non-nucleoside ribonuclease A inhibitors.
1,2,3-triazole
1,3,5-substituted benzoic acid
Biophysical study
Competitive inhibitors
Docking
Meta-substituted phenyl ring
Ribonuclease A
Sulfonic acids
Journal
Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298
Informations de publication
Date de publication:
01 10 2022
01 10 2022
Historique:
received:
05
03
2022
revised:
15
06
2022
accepted:
15
06
2022
pubmed:
10
8
2022
medline:
9
9
2022
entrez:
9
8
2022
Statut:
ppublish
Résumé
Ribonuclease A is used as a model enzyme system for the design of RNase inhibitors. Previous studies have established that the geometric nature of the active site cleft is an important feature for the accommodation of crescent-shaped compounds in the active site of RNase A. In the current research, benzene-based triazolylated semicircular hybrid molecules carrying different polar functionalities were synthesized and screened for their RNase A inhibitory potency. An additional carboxylic acid group at the C1-position of the 1,3,5-trisubstituted benzene ring enhanced the inhibitory properties significantly. Furthermore, the studies revealed that the reduced arm lengths of 3,5-substituents result in a better geometric complementarity that makes the molecules fit favorably in the semicircular cavity of the active site as visualized by docking studies. In a series of ten such new compounds, the 3,5-bis[4-(sulfomethyl)-1H-1,2,3-triazol-1-yl]benzoic acid exhibited, the highest inhibition efficiency with a K
Identifiants
pubmed: 35944385
pii: S0968-0896(22)00280-2
doi: 10.1016/j.bmc.2022.116888
pii:
doi:
Substances chimiques
Benzene Derivatives
0
Enzyme Inhibitors
0
Ribonucleases
EC 3.1.-
Ribonuclease, Pancreatic
EC 3.1.27.5
Benzene
J64922108F
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
116888Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.